Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Completed · Phase 3
Conditions studied: Locally Advanced or Metastatic Unresectable Urothelial Cancer
In brief
The primary objective of this study is to assess overall survival (OS) with sacituzumab govitecan-hziy in comparison with treatment of physician's choice (TPC) in participants with metastatic or locally advanced unresectable urothelial cancer (UC).
Key facts
- Study ID
- NCT04527991
- Run by
- Gilead Sciences
- People needed
- 711
- Starts
- 2021-01-13
- Expected to finish
- 2025-07-04
- Last updated by the study team
- 2026-06-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UCLA Hematology/ Oncology — Los Angeles, California, United States
- University of California Irvine (UCIMC) — Orange, California, United States
- MedStar Washington Hospital Center — Washington D.C., District of Columbia, United States
- Baptist MD Anderson Cancer Center — Jacksonville, Florida, United States
- Boca Raton Clinical Research Global USA - Plantation — Plantation, Florida, United States
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- University of Maryland School of Medicine — Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- Weill Cornell Medical College — New York, New York, United States
- Montefiore Medical Center — The Bronx, New York, United States
- Cleveland Clinic — Cleveland, Ohio, United States
- Oklahoma Cancer Specialists and Research Institute (OCSRI) — Tulsa, Oklahoma, United States
- Penn State Hershey Cancer Institute — Hershey, Pennsylvania, United States
- Thompson Oncology Group - Knoxville Downtown — Knoxville, Tennessee, United States
- University Cancer Specialists - Knoxville — Knoxville, Tennessee, United States
- Harold C. Simmons Comprehensive Cancer Center — Dallas, Texas, United States
- Center for Cancer and Blood Disorders — Fort Worth, Texas, United States
- Seattle Cancer Care Alliance (SCCA) — Seattle, Washington, United States
- Summit Cancer Centers — Spokane, Washington, United States
- Chris O'Brien Lifehouse — North Ryde, New South Wales, Australia
- Calvary Mater Newcastle — Waratah, New South Wales, Australia
- Westmead Hospital — Westmead, New South Wales, Australia
- Icon Cancer Centre Wesley — Auchenflower, Queensland, Australia
- Mayo Clinic - Arizona — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.